|
KMID : 0620920070390020195
|
|
Experimental & Molecular Medicine
2007 Volume.39 No. 2 p.195 ~ p.204
|
|
|
Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells
|
|
Park Hye-Young
Jeon Yoon-Kyung
Shin Hyun-Jin
Kim Il-Jin
Kang Hio-Chung
Sook-Jung Jeong
Chung Doo-Hyun
Lee Chang-Woo
|
|
|
Abstract
|
|
|
|
The BubR1 mitotic-checkpoint protein monitors proper attachment of microtubules to kinetochores, and links regulation of chromosome-spindle attachment to mitotic-checkpoint signaling. Thus, disruption of BubR1 activity results in a loss of checkpoint control, chromosomal instability caused by a premature anaphase, and/or the early onset of tumorigenesis. The mechanisms by which deregulation and/or abnormalities of BubR1 expression operate, however, remain to be elucidated. In this study, we demonstrate that levels of BubR1 expression are significantly increased by demethylation. Bisulfite sequencing analysis revealed that the methylation status of two CpG sites in the essential BubR1 promoter appear to be associated with BubR1 expression levels. Associations of MBD2 and HDAC1 with the BubR1 promoter were significantly relieved by addition of 5-aza-2’-deoxycytidine, an irreversible DNA methyltransferase inhibitor. However, genomic DNA isolated from 31 patients with colorectal carcinomas exhibited a +84A/G polymorphic change in approximately 60% of patients, but this polymorphism had no effect on promoter activity. Our findings indicate that differential regulation of BubR1 expression is associated with changes in BubR1 promoter hypermethylation patterns, but not with promoter polymorphisms, thus providing a novel insight into the molecular regulation of BubR1 expression in human cancer cells.
|
|
|
KEYWORD
|
|
|
Bub1 spindle checkpoint protein, colorectal neoplasms, DNA methylation, polymorphism, genetic
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|
|